353 related articles for article (PubMed ID: 16546214)
21. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
22. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
23. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
24. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
25. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
[TBL] [Abstract][Full Text] [Related]
26. Acamprosate: A Review of Its Use in Alcohol Dependence.
Plosker GL
Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
[TBL] [Abstract][Full Text] [Related]
27. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
[TBL] [Abstract][Full Text] [Related]
28. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
[TBL] [Abstract][Full Text] [Related]
29. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
30. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
[TBL] [Abstract][Full Text] [Related]
31. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
[TBL] [Abstract][Full Text] [Related]
32. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
33. Acamprosate campral for alcoholism.
Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336
[TBL] [Abstract][Full Text] [Related]
34. Acamprosate and its efficacy in treating alcohol dependent adolescents.
Niederhofer H; Staffen W
Eur Child Adolesc Psychiatry; 2003 Jun; 12(3):144-8. PubMed ID: 12768462
[TBL] [Abstract][Full Text] [Related]
35. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P
Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500
[TBL] [Abstract][Full Text] [Related]
37. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
Mason BJ; Lehert P
Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
[TBL] [Abstract][Full Text] [Related]
38. Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy.
Perney P; Lehert P; Mason BJ
Alcohol Alcohol; 2012; 47(2):133-9. PubMed ID: 22218671
[TBL] [Abstract][Full Text] [Related]
39. Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal.
Berger L; Brondino M; Fisher M; Gwyther R; Garbutt JC
J Am Board Fam Med; 2016; 29(1):37-49. PubMed ID: 26769876
[TBL] [Abstract][Full Text] [Related]
40. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M; Chick J
Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
